Na łamach SCIENCE , November 27 2009, 326 (5957) wiele ciekawych wypowiedzi i przemyśleń pod hasłem Science and the Stimulus.
Warto się z nimi zapoznać i zacząć wymagać od polskich decydentów (niezmiennie epatujących nadaną im zewnętrznie mocą) o zmianach strukturalnych w nauce, a którym zdecydowanie brakuje umiejętności zarówno przedstawiania swoich poglądów jak też zmierzania się z poglądami innych...
Shovel-Ready Science Drives DOE Decisions Jeffrey Mervis:
While the Recovery Act was working its way through Congress, a handful of prominent physicists and science lobbyists compiled a list for Congress and the new Administration of all the "shovel-ready" research infrastructure projects at the Department of Energy (DOE)—those approved and ready to go out for bids. Congress used this list along with one compiled by DOE staff as a guide in deciding to give DOE's science programs $1.6 billion in the final bill. Another $400 million went to the Advanced Research Projects Agency-Energy, a new research entity housed within the office of the energy secretary. The use of the recovery money to speed up projects already in the agency's queue is expected to pay both scientific and fiscal dividends.
NSF Boosts Success Rates, But at What Price? Jeffrey Mervis
The National Science Foundation's (NSF's) slice of the so-called stimulus bill added $3 billion to its regular $6.5 billion budget for 2009. That huge increase was based on the repeated complaint from NSF Director Arden Bement in congressional testimony that the agency received billions of dollars' worth of good research proposals each year that it couldn't fund. Bement decided to use the recovery funds to whittle down NSF's huge backlog of highly rated proposals and raise success rates. Bement also told program officers to give priority to young investigators and to "high-risk, high-reward research." But those higher success rates may not last for long, warn some science lobbyists, if Congress fails to deliver on a promised doubling of NSF's budget over 10 years.
Medicine Under the Microscope Eliot Marshall
NIH Hopes Stimulus Isn't a Roller-Coaster Ride Jocelyn Kaiser
